Eligibility Hypertension NCT00237588

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
essential hypertension with diastolic blood pressure 95-110 mmhg and systolic blood pressure < 180 mmhg
Descrição

Essential Hypertension | Diastolic blood pressure | Systolic Pressure

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0085580
UMLS CUI [2]
C0428883
UMLS CUI [3]
C0871470
previously untreated hypertension or treated with monotherapy (but not with ace-inhibitors or angiotensin ii-receptor blockers)
Descrição

hypertension untreated | Therapeutic procedure Hypertensive disease | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0745134
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0020538
UMLS CUI [3]
C0003015
UMLS CUI [4]
C0521942
impaired glucose tolerance or impaired fasting glucose (fasting plasma glucose; 6.1-7.0 mmol/l (110-126 mg/dl)
Descrição

Impaired glucose tolerance | Impaired fasting glycaemia | Plasma fasting glucose measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0271650
UMLS CUI [2]
C1272092
UMLS CUI [3]
C0583513
age over 18
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
informed consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
any one of these: microalbuminuria (urin excretion >20 microg/min), dyslipidemia (hdl-cholesterol <0.9 mmol/l(35 mg/dl), triglycerides > 1.7 mmol/l (150 mg/dl), waist to hip-ratio >0.9 in men and >0.85 in women, bmi >28 kg/m2.
Descrição

Microalbuminuria | Dyslipidemias | Serum HDL cholesterol measurement | Triglycerides measurement | Waist-Hip Ratio | Gender | Body mass index

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0730345
UMLS CUI [2]
C0242339
UMLS CUI [3]
C0428472
UMLS CUI [4]
C0202236
UMLS CUI [5]
C0205682
UMLS CUI [6]
C0079399
UMLS CUI [7]
C1305855
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous or current use of ace-inhibitors or angiotensin ii-receptor blockers
Descrição

Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0003015
UMLS CUI [2]
C0521942
previous or current antidiabetic medications
Descrição

Antidiabetics

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0935929
"brittle" pre-diabetes where the investigator anticipates pharmacological treatment within next 6 months
Descrição

Prediabetes syndrome | Pharmacotherapy Anticipated

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0362046
UMLS CUI [2,1]
C0013216
UMLS CUI [2,2]
C3840775
hypertensive patients where the investigator anticipates polytherapy within next 6 months
Descrição

Hypertensive | Combination Drug Therapy Anticipated

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0857121
UMLS CUI [2,1]
C0013218
UMLS CUI [2,2]
C3840775
female patient who is pregnant or nursing or planning pregnancy within the duration of the study
Descrição

Pregnancy | Breast Feeding | Pregnancy, Planned

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992

Similar models

Eligibility Hypertension NCT00237588

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Essential Hypertension | Diastolic blood pressure | Systolic Pressure
Item
essential hypertension with diastolic blood pressure 95-110 mmhg and systolic blood pressure < 180 mmhg
boolean
C0085580 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
C0871470 (UMLS CUI [3])
hypertension untreated | Therapeutic procedure Hypertensive disease | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
previously untreated hypertension or treated with monotherapy (but not with ace-inhibitors or angiotensin ii-receptor blockers)
boolean
C0745134 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0020538 (UMLS CUI [2,2])
C0003015 (UMLS CUI [3])
C0521942 (UMLS CUI [4])
Impaired glucose tolerance | Impaired fasting glycaemia | Plasma fasting glucose measurement
Item
impaired glucose tolerance or impaired fasting glucose (fasting plasma glucose; 6.1-7.0 mmol/l (110-126 mg/dl)
boolean
C0271650 (UMLS CUI [1])
C1272092 (UMLS CUI [2])
C0583513 (UMLS CUI [3])
Age
Item
age over 18
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Microalbuminuria | Dyslipidemias | Serum HDL cholesterol measurement | Triglycerides measurement | Waist-Hip Ratio | Gender | Body mass index
Item
any one of these: microalbuminuria (urin excretion >20 microg/min), dyslipidemia (hdl-cholesterol <0.9 mmol/l(35 mg/dl), triglycerides > 1.7 mmol/l (150 mg/dl), waist to hip-ratio >0.9 in men and >0.85 in women, bmi >28 kg/m2.
boolean
C0730345 (UMLS CUI [1])
C0242339 (UMLS CUI [2])
C0428472 (UMLS CUI [3])
C0202236 (UMLS CUI [4])
C0205682 (UMLS CUI [5])
C0079399 (UMLS CUI [6])
C1305855 (UMLS CUI [7])
Item Group
C0680251 (UMLS CUI)
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
previous or current use of ace-inhibitors or angiotensin ii-receptor blockers
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
Antidiabetics
Item
previous or current antidiabetic medications
boolean
C0935929 (UMLS CUI [1])
Prediabetes syndrome | Pharmacotherapy Anticipated
Item
"brittle" pre-diabetes where the investigator anticipates pharmacological treatment within next 6 months
boolean
C0362046 (UMLS CUI [1])
C0013216 (UMLS CUI [2,1])
C3840775 (UMLS CUI [2,2])
Hypertensive | Combination Drug Therapy Anticipated
Item
hypertensive patients where the investigator anticipates polytherapy within next 6 months
boolean
C0857121 (UMLS CUI [1])
C0013218 (UMLS CUI [2,1])
C3840775 (UMLS CUI [2,2])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
female patient who is pregnant or nursing or planning pregnancy within the duration of the study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])